Related Experiment Video
Updated: Apr 16, 2026
Isolation and Differentiation of Primary Myoblasts from Mouse Skeletal Muscle Explants
Published on: October 15, 2019
Myc mouse and anti-ageing therapy
1Institute of Healthy Ageing, Department of Genetics, Evolution and Environment, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK.
Abstract:
Reduction in the expression and activity of a well-known proto-oncogene, Myc, has a beneficial effect on mouse health and survival to old age, in part independently of cancer impact, a recent study reveals. Is this new anti-ageing intervention pointing a way towards new treatments for age-related diseases?
Insights
Reducing the expression of the proto-oncogene Myc benefits mouse health and longevity, potentially independent of cancer effects. This finding may offer new avenues for treating age-related diseases.
Area of Science:
- Oncology
- Gerontology
- Molecular Biology
Background:
- The proto-oncogene Myc plays a critical role in cell proliferation and is frequently dysregulated in cancer.
- Aging is associated with increased cellular dysfunction and susceptibility to disease.
Purpose of the Study:
- To investigate the impact of reducing Myc expression and activity on healthspan and lifespan in mice.
- To determine if the effects of Myc reduction are independent of its role in cancer.
Main Methods:
- Utilized genetic manipulation to reduce Myc expression and activity in a mouse model.
- Assessed various health parameters, survival rates, and cancer incidence.
Main Results:
- A significant reduction in Myc expression and activity led to improved mouse health and extended survival to old age.
- These beneficial effects were observed, in part, independently of a reduction in cancer impact.
Conclusions:
- Targeting Myc offers a promising strategy for promoting healthy aging and potentially mitigating age-related diseases.
- Further research into Myc's role in aging could reveal novel therapeutic targets.
